These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36387892)

  • 1. Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis.
    Wang A; Wang Y; Liu H; Hu X; Li J; Xu H; Nie Z; Zhang L; Lyu Z
    Front Endocrinol (Lausanne); 2022; 13():1027841. PubMed ID: 36387892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis.
    Shi S; Lu C; Tian H; Ren Y; Chen T
    Front Endocrinol (Lausanne); 2020; 11():574151. PubMed ID: 33101208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk.
    Trandafir AI; Gheorghe AM; Sima OC; Ciuche A; Petrova E; Nistor C; Carsote M
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone health and aldosterone excess.
    Ceccoli L; Ronconi V; Giovannini L; Marcheggiani M; Turchi F; Boscaro M; Giacchetti G
    Osteoporos Int; 2013 Nov; 24(11):2801-7. PubMed ID: 23695421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone involvement in aldosteronism.
    Salcuni AS; Palmieri S; Carnevale V; Morelli V; Battista C; Guarnieri V; Guglielmi G; Desina G; Eller-Vainicher C; Beck-Peccoz P; Scillitani A; Chiodini I
    J Bone Miner Res; 2012 Oct; 27(10):2217-22. PubMed ID: 22589146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting parathyroid hormone levels in different types of primary aldosteronism.
    Jiang Y; Zhang C; Ye L; Su T; Zhou W; Jiang L; Zhang Y; Wang W
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):267-74. PubMed ID: 26589237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone health among patients with primary aldosteronism: a systematic review and meta-analysis.
    Loh HH; Yee A; Loh HS
    Minerva Endocrinol; 2019 Dec; 44(4):387-396. PubMed ID: 30482008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels.
    Tuersun T; Luo Q; Zhang Z; Wang G; Zhang D; Wang M; Wu T; Zhou K; Yue N; Li N
    Hypertens Res; 2020 Dec; 43(12):1413-1420. PubMed ID: 32770102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
    Pilz S; Kienreich K; Drechsler C; Ritz E; Fahrleitner-Pammer A; Gaksch M; Meinitzer A; März W; Pieber TR; Tomaschitz A
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E75-9. PubMed ID: 22013107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
    Liu Z; Su G; Guo X; Wu Y; Liu X; Zou C; Zhang L; Yang Q; Xu Y; Ma W
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010350. PubMed ID: 26376110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Bone Metabolism in Morbidly Obese Patients After Bariatric Surgery: A Meta-Analysis.
    Liu C; Wu D; Zhang JF; Xu D; Xu WF; Chen Y; Liu BY; Li P; Li L
    Obes Surg; 2016 Jan; 26(1):91-7. PubMed ID: 25982806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism as a cause of secondary osteoporosis.
    Salcuni AS; Carnevale V; Battista C; Palmieri S; Eller-Vainicher C; Guarnieri V; Pugliese F; Guglielmi G; Desina G; Minisola S; Chiodini I; Scillitani A
    Eur J Endocrinol; 2017 Nov; 177(5):431-437. PubMed ID: 28794160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
    Mitra D; Elvins DM; Collins AJ
    J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review.
    Manosroi W; Phudphong P; Atthakomol P; Phimphilai M
    BMC Endocr Disord; 2022 Aug; 22(1):217. PubMed ID: 36045354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.
    Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ
    Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis.
    Thongprayoon C; Acharya P; Aeddula NR; Torres-Ortiz A; Bathini T; Sharma K; Ungprasert P; Watthanasuntorn K; Suarez MLG; Salim SA; Kaewput W; Chenbhanich J; Mao MA; Cheungpasitporn W
    Arch Osteoporos; 2019 Mar; 14(1):35. PubMed ID: 30852679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone and mineral metabolism in patients with primary aldosteronism.
    Petramala L; Zinnamosca L; Settevendemmie A; Marinelli C; Nardi M; Concistrè A; Corpaci F; Tonnarini G; De Toma G; Letizia C
    Int J Endocrinol; 2014; 2014():836529. PubMed ID: 24864141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report.
    Diamond T; Ng AT; Levy S; Magarey C; Smart R
    Osteoporos Int; 1996; 6(4):329-33. PubMed ID: 8883124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.